Dataset Information

Danshenol B alleviates central post-stroke pain by regulating PIK3CG/NLRP3 signaling pathway

ABSTRACT: Background: Central post-stroke pain (CPSP) severely impairs quality of life and is challenging to manage, potentially leading to self-harm or suicide. Although Compound Salvia miltiorrhiza (Danshen) is effective against neuropathic pain, its specific active components and mechanisms remain unclear. Study design and methods: We established a CPSP mouse model and performed RNA sequencing on the ipsilateral Ventral posterolateral thalamic nucleus and Ventral posteromedial thalamic nucleus (VPL/VPM) to identify differentially expressed genes (DEGs). DEGs were analyzed through network pharmacology and molecular docking to assess interactions with 42 Danshen components. We evaluated the effects of varying Danshenol B concentrations, administered daily into the VPL/VPM, on CPSP. Changes in PIK3CG and NLRP3 were monitored to determine Danshenol B’s analgesic effects. Additionally, we overexpressed and knocked down PIK3CG to examine its role in CPSP and assessed NLRP3 to explore if it acts downstream of PIK3CG. Results: In the CPSP model, 409 DEGs were identified in the VPL/VPM, involved in pathways like signal transduction and NOD-like receptor signaling. Network pharmacology linked 21 Danshen components to 11 DEGs. Molecular docking showed strong binding affinities (≤ −7.00 kcal/mol) between four Danshen components—tanshinaldehyde, sclareol, MOL007155, and Danshenol B—and proteins including BTK, CASP1, MMP9, and PIK3CG. Danshenol B (0.5 μM) significantly alleviated CPSP and reduced PIK3CG and NLRP3 protein. PIK3CG overexpression increased NLRP3 and counteracted Danshenol B’s effects, while its knockdown induced CPSP and reduced NLRP3 expression. Conclusion: Danshenol B alleviates CPSP by suppressing the PIK3CG/NLRP3 signaling pathway, clarifying its therapeutic mechanism, and highlighting its potential in analgesic drug development.

ORGANISM(S): Mus musculus

PROVIDER: GSE281041 | GEO | 2025/06/25

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Osteoarthritis (OA) is a debilitating joint disorder characterized by cartilage degradation and chondrocyte homeostasis disruption. Although retinoic acid (RA) has been applied in the model preparation of OA, its target of action and signaling pathway are not clear. Leveraging a translational framework that integrates RNA-sequencing transcriptomics, network pharmacology prediction, computational ligand-receptor molecular docking, and biological experimental validation, this study systematically deciphers RA's disease-modifying targets and associated signaling circuitry in OA pathogenesis. RNA-sequencing of RA-treated chondrocytes revealed 656 differentially expressed genes (DEGs). Protein-protein interaction (PPI) network analysis and functional enrichment (GO/KEGG) highlighted key pathways, including extracellular matrix reorganization and PI3K-Akt-mediated mechanotransduction and others. Additionally, molecular docking results ranked binding affinities in descending order as follows: ACAN > SFRP2 > KANSL2 (NSL2), and so on. Network pharmacology identified 42 RA-OA shared targets, with protein-protein interaction (PPI) analysis and functionally enriched (GO/KEGG) including the Renin-angiotensin system, Neuroactive ligand-receptor interaction, and others. The molecular docking results showed a total score in descending order of MAPK14(p38α), PTGER3(PGE2-R), CA2(CACNA2D2), and so on. Five intersecting targets (CA2, ACE, PTGS1(COX-1), PGR, and EDNRA(ETAR) ) from RNA-sequencing and network pharmacology were obtained, and molecular docking was used to dock the intersecting targets to RA. The docking results demonstrated strong binding affinities, which were further validated through western blot and RT-qPCR experiments, confirming the RA-induced upregulation of the intersecting targets. These findings were accompanied by immunofluorescent evidence showing elevated levels of MMP13 and suppressed expression of COL2A1, collectively reflecting the phenotypic characteristics of OA. Our findings position CA2 and ACE as key hubs for multi-targeting. This study not only reveals possible mechanistic studies of RA in OA but also provides a drug reference for the development of drugs against OA.

Project description:Inflammasome, activated by pathogen-derived and host-derived danger signals, constitutes a multimolecular signaling complex that serves as a platform for caspase-1 (CASP1) activation and interleukin-1beta (IL1B) maturation. The activation of NLRP3 inflammasome requires two-step signals. The first “priming” signal (Signal 1) enhances gene expression of inflammasome components. The second “activation” signal (Signal 2) promotes the assembly of inflammasome components. Deregulated activation of NLRP3 inflammasome contributes to the pathological processes of Alzheimer’s disease (AD) and multiple sclerosis (MS). However, at present, the precise mechanism regulating NLRP3 inflammasome activation and deactivation remains largely unknown. By genome-wide gene expression profiling, we studied the molecular network of NLRP3 inflammasome activation-responsive genes in a human monocyte cell line THP-1 sequentially given two-step signals. We identified the set of 83 NLRP3 inflammasome activation-responsive genes. Among them, we found the NR4A nuclear receptor family NR4A1, NR4A2, and NR4A3, the EGR family EGR1, EGR2, and EGR3, the IkappaB family NFKBIZ, NFKBID, and NFKBIA as a key group of the genes that possibly constitute a negative feedback loop for shutting down inflammation following NLRP3 inflammasome activation. By molecular network analysis, we identified a complex network of NLRP3 inflammasome activation-responsive genes involved in cellular development and death, and immune and inflammatory responses, where transcription factors AP-1, NR4A, and EGR serve as a hub. Thus, NLRP3 inflammasome activation-responsive genes constitute the molecular network composed of a set of negative feedback regulators for prompt resolution of inflammation. To load the Signal 1 (S1), THP-1 cells were incubated for 3 hours in the culture medium with or without inclusion of 0.2 microgram/ml lipopolysaccharide (LPS). To load the Signal 2 (S2), they were incubated further for 2 hours in the culture medium with inclusion of 10 microM nigericin sodium salt dissolved in ethanol or the equal v/v% concentration of ethanol (vehicle), followed by processing for microarray analysis on Human Gene 1.0 ST Array (Affymetrix).

Dataset Information

Danshenol B alleviates central post-stroke pain by regulating PIK3CG/NLRP3 signaling pathway

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets